WHO ICTRP trial
Bioequivalence study of pantoprazole 40 mg tablets
IRCT20130626013776N37 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20130626013776N37 |
|---|---|
| Public title | Bioequivalence study of pantoprazole 40 mg tablets |
| Scientific title | A study to compare the relative bioavailability of Kharazmi and Takeda formulations of pantoprazole 40 mg tablets in 24 healthy adult volunteers under fasting conditions |
| Primary sponsor | Kharazmi Company |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | Bioequivalence |
| Countries | Iran (Islamic Republic of) |
| Conditions | .. |
| Interventions | Intervention 1: Intervention group: Oral administration of a single 40 mg dose of pantoprazole (1 tablet) manufactured by Kharazmi Company to healthy volunteers under fasting condition in the morning of the experiment day. Intervention 2… |
| Registration date | Apr 20, 2021 |
| Target size | 24 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: